Prostate Cancer with Intraluminal Inclusions: the Association of the Immunophenotype with Grade Score

سال انتشار: 1398
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 268

فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJP-14-3_005

تاریخ نمایه سازی: 1 مهر 1398

چکیده مقاله:

Background & Objective: To study the immunophenotype of prostate cancer (PC) with the presence and absence of intraluminal inclusions (IIn), depending on the grade score. Methods: A total of 30 PC samples with IIn (group E) and 30 PC samples without them (group C) were studied. These groups were divided into 2 subgroups, depending on the grade of malignancy, which was determined according to the Gleason score as moderate and high-grade tumors. Macroscopic analysis, hematoxylin-eosin staining, immunohistochemistry (androgen receptors, p53 and Bax proteins, Hsp70 and Hsp90, CD68, VEGF, OSN, MMP-1) were used. Results: The expression level of VEGF was higher in the more differentiated tumors of the control group (P<0.01). Increased expression of prognostic-adverse markers p53 (in the presence of IIn, P<0.01) and MMP-1 (P<0.05) was observed. Also, a higher level of OSN expression was found in PC tissue with IIn (P<0.01) due to its participation in the processes of biomineralization. The expression level of CD68 and Bax protein was higher in the PC group with IIn (both P<0.01). Furthermore, Hsp90 had a significantly lower expression level in the PC of group E (P<0.05). Conclusion: the presence of IIn in the PC samples of group E promotes tissue remodeling with mechanical trauma, chronic inflammation, and fibrosis development. The presence of IIn in PC leads to the increase of OSN, CD68 and Bax expression and decrease of Hsp90 and VEGF expression. High expression of p53 and MMP-1 and low expression of OSN and VEGF was identified as a characteristic of high-grade tumors.

نویسندگان

Artem Piddubnyi

Department of Pathology, Medical Institute, Sumy State University, Sumy, Ukraine

Anatolii Romaniuk

Department of Pathology, Medical Institute, Sumy State University, Sumy, Ukraine.

Inna-Margaryta Radomychelski

Department of Pathology, Medical Institute, Sumy State University, Sumy, Ukraine

Yuliia Moskalenko

Department of Surgery and Oncology, Medical Institute, Sumy State University, Sumy, Ukraine

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Cronin KA, Lake AJ, Scott S, Sherman RL, Noone AM, ...
  • Sfanos KS, De Marzo AM. Prostate cancer and inflammation: the ...
  • Shoskes DA, Lee CT, Murphy D, Kefer J, Wood HM. ...
  • Torkko KC, Wilson RS, Smith EE, Kusek JW, van Bokhoven ...
  • Roberts E, Cossigny DAF, Quan GMY. The role of vascular ...
  • Chatterjee S, Burns TF. Targeting Heat Shock Proteins in Cancer: ...
  • Pulukuri SM, Rao JS. Matrix metalloproteinase-1 promotes prostate tumor growth ...
  • Johnson MI, Robinson MC, Marsh C, Robson CN, Neal DE, ...
  • Fujita K, Nonomura N. Role of Androgen Receptor in Prostate ...
  • Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, ...
  • Guo X, Zhang C, Guo Q, Xu Y, Feng G, ...
  • Moskalenko R, Romanyuk А, Danilchenko S, Stanislavov O, Piddubniy A, ...
  • Sfanos KS, Wilson BA, De Marzo AM, Isaacs WB. Acute ...
  • Banerjee P, Banerjee S, Brown T, Zirkin B. Androgen action ...
  • Mohler JL. A role for the androgen-receptor in clinically localized ...
  • Levesque A, Eastman A. p53-based cancer therapies: Is defective p53 ...
  • Thomas DJ, Robinson M, King P, Hasan T, Charlton R, ...
  • Khor LY, Desilvio M, Li R, McDonnell TJ, Hammond ME, ...
  • Khor LY, Moughan J, Al-Saleem T, Hammond EH, Venkatesan V, ...
  • Jindala DG, Jindalb V, Joshia S, Bhojiac I, Chawdhryc A. ...
  • Kurahashi T, Miyake H, Hara I, Fujisawa M. Expression of ...
  • Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, ...
  • Lebret T, Watson RW, Fitzpatrick JM. Heat shock proteins: their ...
  • Nolan KD, Kaur J, Isaacs JS. Secreted heat shock protein ...
  • Zhang C, Song X, Zhu M, Shi S, Li M, ...
  • Zhong WD, Han ZD, He HC, Bi XC, Dai QS, ...
  • Pulukuri SM, Rao JS. Matrix metalloproteinase-1 promotes prostate tumor growth ...
  • Kervancioglu E, Kosan M, Erinanc H, Gonulalan U, Oguzulgen AI, ...
  • Gautam KA, Singh AN, Srivastav AN, Sankhwar SN. Angiogenesis in ...
  • Weber DC, Tille JC, Combescure C, Egger JF, Laouiti M, ...
  • Lanciotti M, Masieri L, Raspollini MR, Minervini A, Mari A, ...
  • Chang DK, Jamiesonaf NB, Grimmondag SM. Stratified Medicine for Pancreatic ...
  • Jacob K, Webber M, Benayahu D, Kleinman HK. Osteonectin promotes ...
  • نمایش کامل مراجع